Search

Your search keyword '"Miyata, Jeffrey"' showing total 13 results
Start Over Author "Miyata, Jeffrey" Publisher american association for cancer research (aacr)
13 results on '"Miyata, Jeffrey"'

1. Abstract PR004: Comparative genomic analysis of novel translocation renal cell carcinoma model reveals molecular mechanisms of disease progression and therapeutic opportunities

Author

Prakasam, Gopinath, primary, Mishra, Akhilesh, additional, Christie, Alana, additional, Miyata, Jeffrey, additional, Tcheuyap, Vanina T., additional, Ye, Hui, additional, Do, Quyen N., additional, Jones, Kevin B., additional, Requena-Komuro, Mai-Carmen, additional, Pedrosa, Ivan, additional, Rakheja, Dinesh, additional, Kapur, Payal, additional, and Brugarolas, James, additional

Published
2023
Full Text
View/download PDF

2. Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

3. Table S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

4. Figure S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

5. Table S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

6. Figure S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

7. Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

8. Table S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

9. Table S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, primary, Brandenburg, Olivia, primary, Saatchi, Faeze, primary, Stevens, Christina, primary, Toffessi Tcheuyap, Vanina, primary, Christie, Alana, primary, Do, Quyen N., primary, Fatunde, Oluwatomilade, primary, Macchiaroli, Alyssa, primary, Wong, So C., primary, Woolford, Layton, primary, Yousuf, Qurratulain, primary, Miyata, Jeffrey, primary, Carrillo, Deyssy, primary, Onabolu, Oreoluwa, primary, McKenzie, Tiffani, primary, Mishra, Akhilesh, primary, Hardy, Tanner, primary, He, Wei, primary, Li, Daniel, primary, Ivanishev, Alexander, primary, Zhang, Qing, primary, Pedrosa, Ivan, primary, Kapur, Payal, primary, Schluep, Thomas, primary, Kanner, Steven B., primary, Hamilton, James, primary, and Brugarolas, James, primary

Published
2023
Full Text
View/download PDF

10. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Author

Ma, Yuanqing, primary, Joyce, Allison, additional, Brandenburg, Olivia, additional, Saatchi, Faeze, additional, Stevens, Christina, additional, Toffessi Tcheuyap, Vanina, additional, Christie, Alana, additional, Do, Quyen N., additional, Fatunde, Oluwatomilade, additional, Macchiaroli, Alyssa, additional, Wong, So C., additional, Woolford, Layton, additional, Yousuf, Qurratulain, additional, Miyata, Jeffrey, additional, Carrillo, Deyssy, additional, Onabolu, Oreoluwa, additional, McKenzie, Tiffani, additional, Mishra, Akhilesh, additional, Hardy, Tanner, additional, He, Wei, additional, Li, Daniel, additional, Ivanishev, Alexander, additional, Zhang, Qing, additional, Pedrosa, Ivan, additional, Kapur, Payal, additional, Schluep, Thomas, additional, Kanner, Steven B., additional, Hamilton, James, additional, and Brugarolas, James, additional

Published
2022
Full Text
View/download PDF

11. Abstract 1234: PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer

Author

Mulgaonkar, Aditi, primary, Woolford, Layton, additional, Elias, Roy, additional, Nham, Kien, additional, Guan, Bing, additional, Hao, Guiyang, additional, Stevens, Christina, additional, Tcheuyap, Vanina Toffessi, additional, Haldeman, Sydney, additional, Miyata, Jeffrey, additional, Carrillo, Deyssy, additional, Qin, Qian (Janie), additional, Singla, Nirmish, additional, Bowman, Isaac, additional, Cadeddu, Jeffrey, additional, Margulis, Vitaly, additional, Christie, Alana, additional, Kapur, Payal, additional, Pedrosa, Ivan, additional, Dakanali, Marianna, additional, Oz, Orhan, additional, Sun, Xiankai, additional, and Brugarolas, James, additional

Published
2022
Full Text
View/download PDF

12. Abstract 2478: Development of a novel HIF2a PET tracer: From proof of concept to a clinical trial

Author

Debnath, Sashi, primary, Stevens, Christina, additional, Brandenburg, Olivia, additional, Sovich, Justin, additional, Gonzalez, Paulina, additional, Qin, Qian (Janie), additional, Haldeman, Sydney, additional, Tcheuyap, Vanina Toffessi, additional, Christie, Alana, additional, Thapa, Pawan, additional, Zhou, Ning, additional, Mulgaonkar, Aditi, additional, Hao, Guiyang, additional, Miyata, Jeffrey, additional, Carrillo, Deyssy, additional, Cadeddu, Jeffrey, additional, Kapur, Payal, additional, Anderson, Jon, additional, Pedrosa, Ivan, additional, Dakanali, Marianna, additional, Oz, Orhan, additional, Sun, Xiankai, additional, and Brugarolas, James, additional

Published
2022
Full Text
View/download PDF

13. Abstract 6304: Targeting HIF2a with siRNA: From preclinical models to the clinic

Author

Ma, Yuanqing, primary, Stevens, Christina, additional, Brandenburg, Olivia, additional, Tcheuyap, Vanina Toffessi, additional, Do, Quyen N., additional, Saatchi, Faeze, additional, Hardy, Tanner, additional, Fatunde, Oluwatomilade, additional, Macchiaroli, Alyssa, additional, Miyata, Jeffrey, additional, Carrillo, Deyssy, additional, Schluep, Thomas, additional, Wong, So, additional, Christie, Alana, additional, Kapur, Payal, additional, Pedrosa, Ivan, additional, Hamilton, James, additional, and Brugarolas, James, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results